ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979